Pulmonology Medical News about Amphotericin B

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Pulmonary Epithelial Lining Fluid Concentrations after Use of Systemic Amphotericin B Lipid Formulations
Antimicrobial Agents and Chemotherapy, 11/05/09

Weiler S et al. – Amphotericin B (AMB) concentrations were determined in pulmonary epithelial lining fluid (ELF) of 44 critically ill patients, who were receiving treatment with liposomal AMB (LAMB), AMB colloidal dispersion (ABCD), or AMB lipid complex (ABLC).

<< Previous
Well-differentiated papillary mesothelioma with invasion to the...

Next >>
Elevated serum levels of TPS and CYFRA 21-1 predict poor...

Continuous infusion of amphotericin B deoxycholate: an innovative, low-cost strategy in antifungal treatment
Mycoses, 10/29/09 Relevance Score: 69%

Diffuse (anergic) cutaneous leishmaniasis responding to amphotericin B
Clinical and Experimental Dermatology, 11/17/09 Relevance Score: 67%

In vitro sensitivity of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Brazilian isolates to meglumine antimoniate and amphotericin B
Tropical Medicine & International Health, 10/28/09 Relevance Score: 67%

Paracoccidioidomycosis
Paediatric Respiratory Reviews, 11/10/09 Relevance Score: 66%

Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B
Critical Care, 10/20/09 Relevance Score: 66%